In This Section

Advocacy Detail

ASPET Addresses Proposed DEA Scheduling Action on Kratom

June 11, 2018

ASPET opposes the DEA’s proposal to place mitragynine and 7-hydroxymitragynine into Schedule 1 of the Controlled Substances Act without further study.

Read the complete statement below.

Categories:
  • Statement
Last Updated: August 15, 2017

Job Postings